193 related articles for article (PubMed ID: 23432164)
1. Incidence of cardiovascular diseases in an Iranian population: the Isfahan Cohort Study.
Talaei M; Sarrafzadegan N; Sadeghi M; Oveisgharan S; Marshall T; Thomas GN; Iranipour R
Arch Iran Med; 2013 Mar; 16(3):138-44. PubMed ID: 23432164
[TBL] [Abstract][Full Text] [Related]
2. The influence of gender and place of residence on cardiovascular diseases and their risk factors. The Isfahan cohort study.
Sarrafzadegan N; Talaei M; Kelishadi R; Toghianifar N; Sadeghi M; Oveisgharan S; Kabiri P; Tavassoli A; Mohammadifard N; Thomas GN; Marshall T
Saudi Med J; 2012 May; 33(5):533-40. PubMed ID: 22588815
[TBL] [Abstract][Full Text] [Related]
3. Heart rate and cardiovascular events: a nested case-control in Isfahan Cohort Study.
Sadeghi M; Talaei M; Zand I; Oveisgharan S; Iranipour R; Esteki Ghashghaei F; Sarrafzadegan N
Arch Iran Med; 2014 Sep; 17(9):633-7. PubMed ID: 25204481
[TBL] [Abstract][Full Text] [Related]
4. Predictor of event-free survival in patients with myocardial infarction.
Henareh L; Berglund M
Acute Card Care; 2012 Sep; 14(3):105-9. PubMed ID: 22934967
[TBL] [Abstract][Full Text] [Related]
5. [Two year follow-up of acute ischemic syndrome without ST elevation].
Tan HQ; Zhu J; Liang Y; Zhang Y; Liu LS;
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):184-8. PubMed ID: 15854465
[TBL] [Abstract][Full Text] [Related]
6. The Isfahan cohort study: rationale, methods and main findings.
Sarrafzadegan N; Talaei M; Sadeghi M; Kelishadi R; Oveisgharan S; Mohammadifard N; Sajjadieh AR; Kabiri P; Marshall T; Thomas GN; Tavasoli A
J Hum Hypertens; 2011 Sep; 25(9):545-53. PubMed ID: 21107436
[TBL] [Abstract][Full Text] [Related]
7. Sudden cardiovascular death rate and ischaemic heart disease death rate changes during the 5-year period of 2003-2008.
Piotrowski W; Polakowska M; Koziarek J; Broda G
Kardiol Pol; 2012; 70(12):1225-34. PubMed ID: 23264239
[TBL] [Abstract][Full Text] [Related]
8. Secular trends in cardiovascular mortality in Iran, with special reference to Isfahan.
Sarraf-Zadegan N; Boshtam M; Malekafzali H; Bashardoost N; Sayed-Tabatabaei FA; Rafiei M; Khalili A; Mostafavi S; Khami M; Hassanvand R
Acta Cardiol; 1999 Dec; 54(6):327-33. PubMed ID: 10672288
[TBL] [Abstract][Full Text] [Related]
9. Impact of metabolic syndrome on ischemic heart disease - a prospective cohort study in an Iranian adult population: Isfahan Cohort Study.
Talaei M; Sadeghi M; Marshall T; Thomas GN; Kabiri P; Hoseini S; Sarrafzadegan N
Nutr Metab Cardiovasc Dis; 2012 May; 22(5):434-41. PubMed ID: 21195593
[TBL] [Abstract][Full Text] [Related]
10. Erectile dysfunction prospectively associated with cardiovascular disease in the Dutch general population: results from the Krimpen Study.
Schouten BW; Bohnen AM; Bosch JL; Bernsen RM; Deckers JW; Dohle GR; Thomas S
Int J Impot Res; 2008; 20(1):92-9. PubMed ID: 17728804
[TBL] [Abstract][Full Text] [Related]
11. Hyperinsulinemia is a predictor of new cardiovascular events in Colombian patients with a first myocardial infarction.
García RG; Rincón MY; Arenas WD; Silva SY; Reyes LM; Ruiz SL; Ramirez F; Camacho PA; Luengas C; Saaibi JF; Balestrini S; Morillo C; López-Jaramillo P
Int J Cardiol; 2011 Apr; 148(1):85-90. PubMed ID: 19923024
[TBL] [Abstract][Full Text] [Related]
12. Stroke and acute myocardial infarction in the Swedish Sami population: incidence and mortality in relation to income and level of education.
Sjölander P; Hassler S; Janlert U
Scand J Public Health; 2008 Jan; 36(1):84-91. PubMed ID: 18426788
[TBL] [Abstract][Full Text] [Related]
13. Opium decreases the age at myocardial infarction and sudden cardiac death: a long- and short-term outcome evaluation.
Roohafza H; Talaei M; Sadeghi M; Haghani P; Shokouh P; Sarrafzadegan N
Arch Iran Med; 2013 Mar; 16(3):154-60. PubMed ID: 23432167
[TBL] [Abstract][Full Text] [Related]
14. Short sleep duration and type 2 diabetes enhance the risk of cardiovascular events in hypertensive patients.
Eguchi K; Hoshide S; Ishikawa S; Shimada K; Kario K
Diabetes Res Clin Pract; 2012 Dec; 98(3):518-23. PubMed ID: 23020940
[TBL] [Abstract][Full Text] [Related]
15. Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events-stroke, acute myocardial infarction, and death from coronary heart disease.
Roumie CL; Choma NN; Kaltenbach L; Mitchel EF; Arbogast PG; Griffin MR
Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1053-63. PubMed ID: 19637402
[TBL] [Abstract][Full Text] [Related]
16. Pre-hypertension, pre-diabetes or both: which is best at predicting cardiovascular events in the long term?
Khosravi A; Gharipour M; Nezafati P; Khosravi Z; Sadeghi M; Khaledifar A; Taheri M; Golshahi J; Sarrafzadegan N
J Hum Hypertens; 2017 Jun; 31(6):382-387. PubMed ID: 27334522
[TBL] [Abstract][Full Text] [Related]
17. Incidence rates of heart failure, stroke, and acute myocardial infarction among Type 2 diabetic patients using insulin glargine and other insulin.
Juhaeri J; Gao S; Dai WS
Pharmacoepidemiol Drug Saf; 2009 Jun; 18(6):497-503. PubMed ID: 19326365
[TBL] [Abstract][Full Text] [Related]
18. [Incidence of sudden cardiac death of urban residents in Beijing].
Zhang L; Li Y; Zhou H; Wang H; Dai Y; Chu L; Wang L; Zhang Y; Hua W; Zhang S
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Jun; 42(6):504-9. PubMed ID: 25164226
[TBL] [Abstract][Full Text] [Related]
19. Rural-urban disparities in the management and health issues of chronic diseases in Quebec (Canada) in the early 2000s.
Vanasse A; Courteau J; Cohen AA; Orzanco MG; Drouin C
Rural Remote Health; 2010; 10(4):1548. PubMed ID: 21039080
[TBL] [Abstract][Full Text] [Related]
20. Incidence of recognized and unrecognized myocardial infarction in men and women aged 55 and older: the Rotterdam Study.
de Torbal A; Boersma E; Kors JA; van Herpen G; Deckers JW; van der Kuip DA; Stricker BH; Hofman A; Witteman JC
Eur Heart J; 2006 Mar; 27(6):729-36. PubMed ID: 16478749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]